|Bid||7.09 x 1000|
|Ask||7.10 x 900|
|Day's Range||7.04 - 7.22|
|52 Week Range||6.70 - 10.94|
|Beta (5Y Monthly)||2.21|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 21, 2022 - Feb 25, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Feb 13, 2020|
|1y Target Est||12.33|
Summit Hotel Properties (INN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 24, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce successful preclinical trials in dogs with osteoarthritis. A case entailing the clinical condition of Goody, an 8-year-old male mixed-breed dog, who was rescued in a terrible condition after he was found tied up with a very short leash, cachectic and wounded, was published. Goody suffers from ...
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 17, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce that it has filed a new PCT patent application entitled "Compositions for Treatment of Vaginal Atrophy" on June 12, 2022, claiming priority from a US provisional patent. Vaginal atrophy is a condition associated with loss of moisture, thinning, and inflammation of the vaginal walls, which can ...